Novovax CEO Stanley Erck speaks at a Coronavirus Task Force meeting in the Cabinet Room of the White House, Monday, March 2, 2020 (Andrew Harnik, AP Images)

CEPI bets $384M on No­vavax’s Covid-19 vac­cine — cov­er­ing R&D and man­u­fac­tur­ing in the ground­break­ing race to beat the pan­dem­ic

No­vavax $NVAX got some bad­ly need­ed seed cash from the Coali­tion for Epi­dem­ic Pre­pared­ness In­no­va­tions — CEPI — back in March that al­lowed them to get start­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.